Copy
View email in a browser

Welcome Our New Faculty

Connect with the newest faculty of the basic science academic departments

Paul Burridge, PhD joined the Department of Pharmacology as an assistant professor in August 2015. He earned a PhD at the University of Nottingham in Human Development and Genetics before pursuing postdoctoral fellowships at Johns Hopkins University in the Institute for Cell Engineering/Pediatric Oncology and Stanford University in Radiology/Cardiology. Prior to joining Feinberg, Burridge was an instructor in Cardiovascular Medicine at Stanford University.

The Burridge lab studies the role of the genome in influencing drug responses, particularly patient-specific responses to chemotherapy agents used to treat breast cancer and pediatric leukemia patients. Burridge was recently elected a Fellow of the American Heart Association conferred by the Council on Functional Genomics and Translational Biology. He is a member of the Center for Molecular Cardiology, Feinberg Cardiovascular Research Institute and the Hematologic Malignancies (HM) Program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Ryan Drenan, PhD joined Northwestern as Associate Professor of Pharmacology in April 2016. He studies the physiological processes regulated by native nicotinic acetylcholine receptors (nAChRs), a large family of ligand gated ion channel proteins. These receptors mediate key aspects of cholinergic signaling in the brain, and are involved in several important cognitive processes, including motivated behavior, affective behavior, attention, and learning/memory. These receptors also mediate the action of nicotine in tobacco products, and Dr. Drenan’s lab is working to elucidate the cellular/molecular mechanisms behind nicotine addiction. His work is currently funded by the National Institute on Drug Abuse (NIDA).
 
Prior to joining Northwestern, Drenan was an Assistant Professor at Purdue University in the Department of Medicinal Chemistry and Molecular Pharmacology. He earned a doctorate in Molecular Cell Biology from Washington University and completed a postdoctoral fellowship at the California Institute of Technology in the lab of Henry A. Lester.  He was recently honored with an American Society for Pharmacology and Experimental Therapeutics (ASPET) Early Career Independent Investigator Award at the ASPET Annual Meeting in San Diego.
Daniel Foltz, PhD joined in July 2015 as associate professor in Biochemistry and Molecular Genetics. He joined Northwestern from the University of Virginia School of Medicine. Research in the Foltz Laboratory focuses on the important basic question of how chromosomes are segregated during cell division to ensure the complete and accurate inheritance of the genome.

Foltz earned a PhD in Cell Biology from Northwestern University and pursued a postdoctoral fellowship in cancer research at the Ludwig Institute for Cancer Research, San Diego.

Foltz co-authored the article Differential Binding Partners of the Mis18a/b YIPPEE Domains Regulate Mis18 Complex Recruitment to Centromeres, which was recently published in Cell Reports, 2016 June 7; 15, 2127–2135. He is a member of the Cancer Epigenetics and Nuclear Dynamics (CEND) program of the Robert H. Lurie Comprehensive Cancer Center. Foltz’s studies are currently supported by two major grants from the National Institutes of Health (NIH).
Marc Mendillo, PhD joined the Department of Biochemistry and Molecular Genetics as assistant professor in September 2015. He earned a PhD in Biomedical Sciences from the University of California at San Diego and completed a postdoctoral fellowship at the Whitehead Institute at MIT.

The long-term goals of the Mendillo Lab are to identify and characterize the systems that promote protein homeostasis, understand how these systems are co-opted and perturbed in malignancy, and ultimately identify means to manipulate them for therapeutic benefit. The lab pursues biochemistry, genetic and chemical biology approaches in conjunction with systematic high-throughput and genomic methods.

Mendillo is a member of the Cancer Epigenetics and Nuclear Dynamics (CEND) program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Mendillo’s studies are funded by a K99/R00 from the National Cancer Institute (NCI), and funding from the Lynn Sage Cancer Research Foundation and the Sidney Kimmel Foundation.
Panagiotis (Panos) Ntziachristos, PhD joined Northwestern in September 2015 as assistant professor in Biochemistry and Molecular Genetics and assistant professor of Medicine in the Division of Hematology/Oncology.  

Ntziachristos studies the mechanistic aspects of oncogenesis with an emphasis on transcriptional and epigenetic regulation of acute leukemia. The goal of his work is to explain how cancer cells differ from other cells to help inform future targeted therapies.

Ntziachristos earned his doctorate at the University of Athens and completed a postdoctoral fellowship at New York University in 2015. His studies are currently funded by a K99/R00 from the National Cancer Institute (NCI), and funding from the American Society of Hematology and the Chicago Region Physical Science-Oncology Center (CR-PSOC).
Pablo Penaloza-MacMaster, PhD joined the Department of Microbiology-Immunology in May 2016 as an assistant professor. The goal of Penaloza's research is to understand the basic mechanisms of immune regulation and to use this information to develop vaccines against HIV and other chronic infections, as well as novel regimens for restoring immune function. The Penaloza laboratory uses various cellular and molecular techniques to study responses in mouse, primate, and human immune systems.  

Prior to joining Feinberg, Penaloza was an assistant professor of Medicine at Harvard University and the Beth Israel Deaconess Medical Center, Center for Virology & Vaccine Research.  He earned a PhD in Immunology and Molecular Pathogenesis from Emory University and completed a postdoctoral fellowship in Virology at Beth Israel Deaconess Medical Center. Penaloza is a member of the Third Coast Center For AIDS Research in Chicago.
Minoli Perera, PharmD, PhD joined as associate professor of Pharmacology in July 2016. Her area of expertise is African American genomic medicine, including: pharmacokinetics, clinical pharmacology and human genetics. Her research is focused on anticoagulant pharmacogenomics, the genomics of drug metabolism, and the pharmacogenomics of inflammatory bowel disease.

Prior to joining Feinberg, Perera was an associate professor within the Section of Genetic Medicine, University of Chicago Department of Medicine. She earned a PharmD from the University of Tennessee and her doctorate in Pharmaceutics from Ohio State University.  Perera completed a fellowship in Clinical Pharmacology and Pharmacogenomics at the University of Chicago.
Basic Science Administration